Expression of calreticulin in breast and cervical cancer in relation to clinical outcome

被引：0
|
作者：
Eric, A. [1 ]
Juranic, Z. [1 ]
Milovanovic, Z. [1 ]
Jovanovic, D. [1 ]
Gavrilovic, D. [1 ]
Borojevic, N. [1 ]
Plesinac, V. [1 ]
Markovic, I. [1 ]
Inic, M. [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, DATA Ctr, Belgrade, Serbia
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71682-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [31] Expression profiling predicts outcome in breast cancer
    Laura J van 't Veer
    Hongyue Dai
    Marc J van de Vijver
    Yudong D He
    Augustinus AM Hart
    René Bernards
    Stephen H Friend
    Breast Cancer Research, 5
  • [32] Expression profiling predicts outcome in breast cancer
    van 't Veer, LJ
    Dai, HY
    van de Vijver, MJ
    He, YDD
    Hart, AAM
    Bernards, R
    Friend, SH
    BREAST CANCER RESEARCH, 2003, 5 (01) : 57 - 58
  • [33] Osteopontin C mRNA expression is associated with a poor clinical outcome in human breast cancer
    Patanil, Neill
    Jiang, Wen
    Mokbel, Kefah
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (11) : 2646 - 2646
  • [34] GRB7 protein over-expression and clinical outcome in breast cancer
    Betsy Ramsey
    Tao Bai
    Amy Hanlon Newell
    Megan Troxell
    Byung Park
    Susan Olson
    Edward Keenan
    Shiuh-Wen Luoh
    Breast Cancer Research and Treatment, 2011, 127 : 659 - 669
  • [35] SEP: Score for expression profile - A novel method for predicting clinical outcome in breast cancer
    Zhang, Z
    Fenstermacher, D
    PROCEEDINGS OF THE 25TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: A NEW BEGINNING FOR HUMAN HEALTH, 2003, 25 : 3707 - 3710
  • [36] Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients
    Zhou, Shu-wei
    Su, Bei-bei
    Zhou, Yong
    Feng, Yue-qing
    Guo, Yu
    Wang, Yun-xiang
    Qi, Pan
    Xu, Sheng
    MEDICAL ONCOLOGY, 2014, 31 (11) : 1 - 6
  • [37] The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome
    Habermann, Jens K.
    Doering, Jana
    Hautaniemi, Sampsa
    Roblick, Uwe J.
    Buendgen, Nana K.
    Nicorici, Daniel
    Kronenwett, Ulrike
    Rathnagiriswaran, Shruti
    Mettu, Rama K. R.
    Ma, Yan
    Krueger, Stefan
    Bruch, Hans-Peter
    Auer, Gert
    Guo, Nancy L.
    Ried, Thomas
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (07) : 1552 - 1564
  • [38] Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients
    Shu-wei Zhou
    Bei-bei Su
    Yong Zhou
    Yue-qing Feng
    Yu Guo
    Yun-xiang Wang
    Pan Qi
    Sheng Xu
    Medical Oncology, 2014, 31
  • [39] LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome
    Stebbing, Justin
    Filipovic, Aleksandra
    Ellis, Ian O.
    Green, Andrew R.
    D'Silva, Tanya Rapoz
    Lenz, Heinz-Josef
    Coombes, R. Charles
    Wang, Tingting
    Lee, Soo-Chin
    Giamas, Georgios
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 537 - 544
  • [40] GRB7 protein over-expression and clinical outcome in breast cancer
    Ramsey, Betsy
    Bai, Tao
    Newell, Amy Hanlon
    Troxell, Megan
    Park, Byung
    Olson, Susan
    Keenan, Edward
    Luoh, Shiuh-Wen
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 659 - 669
12345